ARTICLE | Company News
Provid, American National Multiple Sclerosis Society deal
May 18, 2009 7:00 AM UTC
The society's not-for-profit technology transfer subsidiary Fast Forward LLC will provide $50,000 in funding for preclinical development of Provid's PV-267 to treat multiple sclerosis. Fast Forward w...